Omeros (OMER) Enterprise Value (2010 - 2026)
Omeros (OMER) reported Enterprise Value of -$135.3 million for Q1 2026, down 158.18% on a YoY basis from $232.6 million in Q1 2025, and up 21.24% sequentially from -$171.8 million in Q4 2025.
Omeros (OMER) Enterprise Value (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Enterprise Value data on file, last reported at -$135.3 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 158.18% year-over-year to -$135.3 million; the trailing twelve-month figure through Mar 2026 stood at -$135.3 million (down 158.18% YoY), and the FY2025 full-year result was -$171.8 million, down 90.61% from the prior year.
- Enterprise Value advanced to -$135.3 million in Q1 2026, from -$171.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$52.4 million in Q1 2025 to a low of -$590.0 million in Q3 2023.
- A 5-year average of -$204.2 million and a median of -$158.9 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 178.53% in 2023 and surged 88.58% in 2025, its largest moves.
- Tracing OMER's Enterprise Value over 5 years: stood at -$194.9 million in 2022, then climbed by 11.84% to -$171.8 million in 2023, then jumped by 47.55% to -$90.1 million in 2024, then tumbled by 90.61% to -$171.8 million in 2025, then increased by 21.24% to -$135.3 million in 2026.
- Business Quant data shows OMER's Enterprise Value at -$135.3 million in Q1 2026, -$171.8 million in Q4 2025, and -$69.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | -135.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.32 Mn |
| Dec 31, 2025 | -171.80 Mn |
| Sep 30, 2025 | -69.79 Mn |
| Jun 30, 2025 | -55.54 Mn |
| Mar 31, 2025 | -52.41 Mn |
| Dec 31, 2024 | -90.13 Mn |
| Sep 30, 2024 | -123.16 Mn |
| Jun 30, 2024 | -158.91 Mn |
| Mar 31, 2024 | -458.80 Mn |
| Dec 31, 2023 | -171.85 Mn |
| Sep 30, 2023 | -589.97 Mn |
| Jun 30, 2023 | -341.28 Mn |
| Mar 31, 2023 | -371.33 Mn |
| Dec 31, 2022 | -194.92 Mn |
| Sep 30, 2022 | -220.96 Mn |
| Jun 30, 2022 | -122.53 Mn |
| Mar 31, 2022 | -142.27 Mn |
| Dec 31, 2021 | -157.26 Mn |
| Sep 30, 2021 | -93.36 Mn |
| Jun 30, 2021 | -73.66 Mn |